our community

The collaborative approach applied by our technological and clinical community nurtures interdisciplinary project development.



PMI mobilizes and coordinates BC’s technological, clinical testing and healthcare delivery resources to bring personalized medicine to BC residents. The PMI is an inclusive initiative that has representation from all the relevant technological, preclinical and clinical communities in BC.

Research findings shape the basis for the personalized medicine translational projects and feeds into our clinical testing platform.

The PMI works closely with research and academic institutions. The expert knowledge and latest advancement from life science, applied science, and natural science research capabilities support all the PMI projects.

The scientific partners include researchers from Life Sciences Institute and Brain Research Centre in University of British Columbia, Proteomics Centre in University of Victoria, and Genome BC, among many other respected institutes.

Expertise to design and conduct innovative clinical trials required for the practice of personalized medicine is made available to the PMI through key partnerships.

Partnering with the BC Clinical Research Infrastructure Network (BCCRIN) and involvement of internationally recognized investigators allow opportunity for a rich clinical integration required to make personalized medicine available for the public.

Among others, the PMI collaborates with investigators at BC Cancer Agency, the Child and Family Research Institute (Children’s Hospital) St. Paul’s Hospital and Vancouver General Hospital.

Strong partnership with technology development ensures benefits are delivered to you and your community.

The PMI takes full advantage of BC’s world leading position in the technology sector: genomics, epigenomics, proteomics, transcriptomics, biochemistry, nanotechnology, information technology, engineering, microfluidics, physics and material science.

Drug development expertise will be provided through collaboration with the Centre for Drug Research and Development (CDRD). Partnered with and based at the Life Sciences Institute at the University of British Columbia, the PMI has the capacity to develop drugs, diagnostics, devices and informatics tools for personalized medicine applications.

The delivery of benefits to individuals, families, and communities is our ultimate goal.

The personalized-medicine approach will guide the healthcare system for improved patient and provider healthcare experiences at sustainable and reduced costs.

The PMI ensures BC residents receive the benefits by setting forth multiple measures. Our web presence acts as a resource for patients and healthcare providers. Public outreach and engagement help develop the policy guidelines. Training programs for physicians, pharmacists, and other key health practitioners ensures personalized medicine can be successfully implemented.

Specialized skills are essential in developing projects and delivering benefits to you and your community.

The PMI cultivates specialized skills through working closely with diverse partners. We bring together talents in business development and marketing. Other collaborators include project managers, designers, and writers.


stakeholders

One of the four objectives of our Roadmap is to establish a coalition of stakeholders to coordinate whole system change to enable personalized medicine. At our weekly meetings, the PMI has been hearing the perspectives of people in government, industry, healthcare and academia. Some of them have agreed to share their presentations here.

2015

Oct 21

Michael Coughtrie

Dean, UBC Pharmaceutical Sciences

Nov 4

Heather Davidson

Assistant Deputy Minister, Ministry of Health

Dec 2

John Jacobson

Deputy Minister, Ministry of Innovation, Technology & Citizens Services

2016

Jan 6

Marc Parlange

Dean, UBC Applied Science

Jan 13

Rob McMaster

VP Research, Vancouver Coastal Health
Pacific Health Innovation eXchange (PHIX)
[slides]

Jan 27

Paul Drohan

President & CEO, LifeSciences BC
LifeSciences BC: Companies to Community to Bio-Cluster
[slides]

Feb 24

Jeff Sumner

Senior VP, Business Development, Clinical Affairs and Genetics, LifeLabs

Mar 2

Sean McKelvey

Pharmacist and co-Founder of the Institute for Personalized Therapeutic Nutrition
Institute for Personalized Therapeutic Nutrition, A Food-First Approach to Healthcare
[slides]

Mar 23

Alison Hoens

Knowledge Broker, Clinical Professor, UBC Faculty of Medicine Department of Physical Therapy, Physiotherapy Association of BC, Vancouver Coastal Health Research Institute, Providence Healthcare Research Institute
Knowledge Translation / Knowledge Brokering & the PMI
[slides]

Apr 27

Brendan Byrne

CIO, TELUS Health

May 18

Bryn Hyndman, MD

Medical Director, Qi Integrated Health
Shifting our Health Care Paradigm:
Understanding and Application of Functional and Precision Medicine in Primary Care

[slides]

Ashley Riskin, MD

Clinic Director and Co-Founder, Connect Health
Functional & Precision Medicine
[slides]

May 25

David Fajgenbaum, MD, MBA, MSc

Assistant Professor of Medicine, Translational Medicine & Human Genetics Associate Director, Patient Impact, Orphan Disease Center, University of Pennsylvania
Co-Founder & Executive Director, Castleman Disease Collaborative Network
Personal Personalized Medicine: lessons learned from the ‘Collaborative Network approach’
[slides]

Jun 15

Andrew Attwell, MD

Doctors of BC Policy on Precision Medicine


funding

Thanks to the funding partners, the PMI community is positioned to take a lead in unraveling medicine’s greatest challenges and providing the data needed by the healthcare system through an evidence-based approach to achieve more precise management of health and treatment of disease. 

Funding Opportunities 

The goal of the PMI is to build capacity and initiatives that continuously meet the challenges of developing and delivering personalized medicine solutions. To achieve this, we are continuously seeking private support to build core research infrastructure and to expand a comprehensive and advanced program.

Investment in our initiatives support leading-edge multidisciplinary research, the recruitment and training of scientists and clinical practitioners and the acquisition of state-of-the-art equipment – all of which would ultimately lead towards improved treatment of diseases and conditions and an improved ability to maintain wellness.

contact us